Accueil   Diary - News   All news Three Novasep custom manufacturing sites renew FDA approval in 2016

Three Novasep custom manufacturing sites renew FDA approval in 2016

Novasep-logo-300dpiLyon, France, December 19, 2016 – Novasep, a leading supplier of services and technologies for the life sciences industry, today announces that three of its custom manufacturing sites individually passed the general inspection process of the US Food and Drug Administration (FDA) free of any 483 form. All three FDA general inspections have taken place at Novasep’s manufacturing sites in France (Mourenx and Le Mans), and in Germany (Leverkusen) over the course of 2016.

 

 

Read the press release